• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.在原发性腮腺恶性肿瘤的风险分层中,临床病理特征比组织学或分级更能作为预后因素。
Head Neck. 2011 Feb;33(2):225-231. doi: 10.1002/hed.21433.
2
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.丹尼尔·丹霍德癌症中心 186 例原发性腮腺癌患者手术联合放疗的长期疗效及生活质量。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):189-95. doi: 10.1016/j.ijrobp.2011.11.045. Epub 2012 Feb 11.
3
Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy.腮腺黏液表皮样癌:切缘极近及辅助性放射治疗
ORL J Otorhinolaryngol Relat Spec. 2019;81(1):55-62. doi: 10.1159/000497438. Epub 2019 Apr 2.
4
Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.腮腺肿瘤的预后因素及临床结局:来自土耳其黑海东部地区一家机构的经验
Asian Pac J Cancer Prev. 2016;17(3):1169-74. doi: 10.7314/apjcp.2016.17.3.1169.
5
Mucoepidermoid carcinoma of the parotid gland: A National Cancer Database study.腮腺黏液表皮样癌:一项国家癌症数据库研究。
Am J Otolaryngol. 2018 May-Jun;39(3):321-326. doi: 10.1016/j.amjoto.2018.03.022. Epub 2018 Mar 14.
6
Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.腮腺黏液表皮样癌:梅奥诊所的经验
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):849-56. doi: 10.1001/archotol.130.7.849.
7
Predictors of recurrence and survival for head and neck mucoepidermoid carcinoma.头颈部黏液表皮样癌的复发和生存预测因素。
Otolaryngol Head Neck Surg. 2013 Sep;149(3):402-8. doi: 10.1177/0194599813489659. Epub 2013 May 21.
8
Positive surgical margins in parotid malignancies: Institutional variation and survival association.腮腺恶性肿瘤的手术切缘阳性:机构差异与生存关联
Laryngoscope. 2019 Jan;129(1):129-137. doi: 10.1002/lary.27221. Epub 2018 Sep 7.
9
Patterns of lymph node metastasis of parotid cancer.腮腺癌的淋巴结转移模式。
Auris Nasus Larynx. 2016 Aug;43(4):446-50. doi: 10.1016/j.anl.2015.11.002. Epub 2015 Dec 4.
10
Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome.腮腺黏液表皮样癌经手术和术后放射治疗:结局的临床病理相关性。
Laryngoscope. 2013 Dec;123(12):3049-55. doi: 10.1002/lary.24238. Epub 2013 Aug 8.

引用本文的文献

1
Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers.分子分析时代的唾液腺癌:组织和液体生物标志物的作用
Cancers (Basel). 2025 Feb 15;17(4):660. doi: 10.3390/cancers17040660.
2
Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors.原发性唾液腺癌复发:发生率、生存率及危险因素
Head Neck. 2025 Jan;47(1):47-56. doi: 10.1002/hed.27880. Epub 2024 Jul 27.
3
MRI-based radiomics for predicting histology in malignant salivary gland tumors: methodology and "proof of principle".基于 MRI 的放射组学预测恶性涎腺肿瘤组织学:方法学和“原理验证”。
Sci Rep. 2024 Apr 30;14(1):9945. doi: 10.1038/s41598-024-60200-9.
4
Non-Squamous Cell Carcinoma of the Larynx: A State-of-the-Art Review.喉非鳞状细胞癌:最新综述
J Pers Med. 2023 Jun 30;13(7):1084. doi: 10.3390/jpm13071084.
5
Pathological Inconsistencies in Advanced Malignancies of the Parotid Gland.腮腺晚期恶性肿瘤的病理不一致性。
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):311-317. doi: 10.1007/s12070-022-03160-8. Epub 2022 Nov 5.
6
Topology-based radiomic features for prediction of parotid gland cancer malignancy grade in magnetic resonance images.基于拓扑学的影像组学特征用于预测磁共振图像中腮腺癌的恶性程度
MAGMA. 2023 Oct;36(5):767-777. doi: 10.1007/s10334-023-01084-0. Epub 2023 Apr 20.
7
Role of Intra-Parotid Lymph Node Metastasis in Primary Parotid Carcinoma.腮腺内淋巴结转移在原发性腮腺癌中的作用。
Life (Basel). 2022 Dec 7;12(12):2053. doi: 10.3390/life12122053.
8
Prognostic models for estimating survival of salivary duct carcinoma: a population-based study.用于估计涎腺癌生存的预后模型:一项基于人群的研究。
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1939-1954. doi: 10.1007/s00405-022-07755-3. Epub 2022 Nov 23.
9
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.曲妥珠单抗辅助治疗 HER-2 阳性涎腺癌的获益。
Oncologist. 2020 Jul;25(7):598-608. doi: 10.1634/theoncologist.2019-0841. Epub 2020 Apr 20.
10
Oncologic outcome and potential prognostic factors in primary squamous cell carcinoma of the parotid gland.腮腺原发性鳞状细胞癌的肿瘤学结果和潜在预后因素。
BMC Cancer. 2019 Jul 31;19(1):752. doi: 10.1186/s12885-019-5969-6.

本文引用的文献

1
Comparison of two prognostic scores for patients with parotid carcinoma.腮腺癌患者两种预后评分的比较。
Head Neck. 2009 Sep;31(9):1188-95. doi: 10.1002/hed.21086.
2
Clinical prognostic factors in malignant parotid gland tumors.腮腺恶性肿瘤的临床预后因素。
Otolaryngol Head Neck Surg. 2005 Nov;133(5):702-8. doi: 10.1016/j.otohns.2005.08.001.
3
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.唾液腺癌:局部区域控制、远处转移及总生存的独立预后因素:荷兰头颈肿瘤协作组的结果
Head Neck. 2004 Aug;26(8):681-92; discussion 692-3. doi: 10.1002/hed.10400.
4
Salivary duct carcinoma.涎腺导管癌
Otolaryngol Head Neck Surg. 2003 Dec;129(6):720-5. doi: 10.1016/S0194-59980301386-X.
5
High incidence of lymph node metastasis in major salivary gland cancer.大唾液腺癌中淋巴结转移的高发生率。
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):720-3. doi: 10.1001/archotol.129.7.720.
6
Carcinoma of the parotid gland.腮腺癌
Am J Surg. 2003 Jul;186(1):57-62. doi: 10.1016/s0002-9610(03)00105-3.
7
Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database.腮腺癌患者的预后指数:使用1985 - 1994年荷兰全国头颈肿瘤协作组数据库进行外部验证
Cancer. 2003 Mar 15;97(6):1453-63. doi: 10.1002/cncr.11254.
8
Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes.唾液腺肿瘤的诊断与分类:病理学挑战及其与临床结果的相关性
Acta Otolaryngol. 2002 Oct;122(7):758-64.
9
Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients.腮腺和颌下腺癌——2465例患者的生存情况研究
Oral Oncol. 2002 Oct;38(7):706-13. doi: 10.1016/s1368-8375(02)00007-6.
10
Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas.
Arch Otolaryngol Head Neck Surg. 2001 Jan;127(1):56-60. doi: 10.1001/archotol.127.1.56.

在原发性腮腺恶性肿瘤的风险分层中,临床病理特征比组织学或分级更能作为预后因素。

Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.

机构信息

Department of Otolaryngology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213.

Departments of Otolaryngology Head & Neck Surgery, LSU Health Sciences Center, New Orleans, LA 70112.

出版信息

Head Neck. 2011 Feb;33(2):225-231. doi: 10.1002/hed.21433.

DOI:10.1002/hed.21433
PMID:21298822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4164959/
Abstract

BACKGROUND

The aim of this study, using a retrospective chart review as the primary study design, was to determine the relative contribution of clinicopathologic risk factors versus low- and high-risk grade histologic groups to assist management of primary parotid cancers.

METHODS

In all, 168 primary parotid malignancies were treated surgically at a tertiary care center from 1982 to 2005. Of these, 115 patients with complete follow-up information were further analyzed. Pathologic updating and reclassification in 28% of cases enabled comparison of tumor histology or grade with current consensus criteria. Clinical outcomes of high- and low-risk histology and grade were compared with the influence of traditional clinicopathologic risk factors.

RESULTS

Of 115 cases, the male:female ratio was equal and the median age was 63 years (range, 15 to 89 years). Mucoepidermoid carcinoma (n = 28) was the most common histology. The median follow-up was 44 months (range, 0–278 months). Of low-risk histology patients who underwent neck dissection 40% had pN+ disease. The median time to recurrence was not reached for low-risk tumors, compared with 29 months for high-risk tumors (p = .0001). Interestingly, extracapsular spread (ECS) and margin status were independent prognostic factors and conferred significantly greater prognostic value than histologic grade risk group. Disease-free survival (DFS) and overall survival (OS) at 5 years for the entire cohort were 51% and 57%, respectively. Risk group was a strong independent predictor of OS but not DFS.

CONCLUSIONS

Risk group defined by histology and grade was associated with DFS. ECS and margin status were independent predictors of DFS. Inclusion of ECS and margin status substantially improved the prediction of disease recurrence, supporting elective neck dissection and postoperative radiotherapy for high-grade tumors or low-risk histologies with positive margins or ECS.

摘要

背景

本研究采用回顾性图表回顾作为主要研究设计,旨在确定临床病理危险因素与低风险和高风险组织学组相对于原发性腮腺癌管理的相对贡献。

方法

在 1982 年至 2005 年期间,在一家三级保健中心对 168 例原发性腮腺恶性肿瘤进行了手术治疗。其中,对 115 例具有完整随访信息的患者进行了进一步分析。在 28%的病例中进行了病理更新和重新分类,使肿瘤组织学或分级与当前的共识标准进行了比较。比较了高风险和低风险组织学和分级的临床结果,以及传统临床病理危险因素的影响。

结果

在 115 例病例中,男女比例相等,中位年龄为 63 岁(范围,15 至 89 岁)。黏液表皮样癌(n = 28)是最常见的组织学类型。中位随访时间为 44 个月(范围,0 至 278 个月)。低风险组织学患者中,行颈清扫术的患者有 40%患有 pN+疾病。低风险肿瘤的中位复发时间未达到,而高风险肿瘤为 29 个月(p =.0001)。有趣的是,包膜外扩散(ECS)和边缘状态是独立的预后因素,比组织学分级风险组具有更大的预后价值。整个队列的 5 年无病生存率(DFS)和总生存率(OS)分别为 51%和 57%。风险组是 OS 的强独立预测因子,但不是 DFS。

结论

通过组织学和分级定义的风险组与 DFS 相关。ECS 和边缘状态是 DFS 的独立预测因子。包括 ECS 和边缘状态可以大大提高疾病复发的预测,支持对高级别肿瘤或低风险组织学伴阳性边缘或 ECS 进行选择性颈清扫术和术后放疗。